Loading
Latest filing published 27 Oct 2023 for Aligos Therapeutics, Inc., €437k. Read the official filing
No signal scores available.
Only one filing by Lawrence Blatt is known so far (27 October 2023): a share grant, €437k, in Aligos Therapeutics, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration